Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.

Slides:



Advertisements
Similar presentations
VA Dataset National Kidney Care Audit. The audit measures two distinct areas: 1. Patient Transport Aim: To make visible the variation of provision and.
Advertisements

NICE Guidance and Quality Standard on Patient Experience
Interpreting the Commissioning for Value Packs
+ Acute Kidney Injury Clinical Directors Forum March 2010 Mark Brady Clinical Advisor, Department of Health.
Monday 17 September (Materials presented to the Mayoral Team on 28 August 2012)
Fylde Coast Integrated Diabetes Care
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
National Institute for Health and Clinical Excellence.
18 week commissioning pathways for kidney disease and renal transplantation Specialty Clinical Leads Lawrence Goldberg: CKD and ESRF pathways John Scoble:
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
How NICE quality Standards can help drive and measure quality improvement Dylan Jones Associate Director - Quality Standards Health and social care quality.
NICE in a changing world North East Leading Improvement for Health and Well- being programme Professor Mike Kelly Director, Centre for Public Health Excellence.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Clinical Lead Self Care and Prevention
NICE in a changing world National Leading Improvement for Health and Well-being programme 12 May 2011 Gillian Mathews Implementation consultant.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
Standards Debate at the Centre for Better Managed Health Care, Cass Business School, City University London, 26 th October Professor Mike Kelly Director.
Introducing NICE... Gateshead Council Gillian Mathews Implementation consultant - north.
RENAL DISEASE IN DIABETES
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Copyright 2011 Right Care The Accountable Integrated Care System Sept 2011 Commissioning for Value.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
NICE quality standard for COPD Craig Grime Technical Analyst Quality Standards NICE
Measuring Output from Primary Medical Care, with Quality Adjustment Workshop on measuring Education and Health Volume Output OECD, Paris 6-7 June 2007.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
These slides were sponsored by Janssen and developed in conjunction with the BRS CKD Strategy Group, following an advisory board that was organised by.
Section 5: Configuration of healthcare to manage CKD.
UKRR Dataset v4.1 How does it fit with the UKRDC ACTIONS IN YOUR RENAL UNIT TO IMPLEMENT THE NEW DATASET UK RENAL REGISTRY 2015 INFORMATICS MEETING: DATA.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
Our Plans for 2015/16 We want to make sure that people in our area are able to live long and healthy lives, both now and in the future, and our plans set.
Developing the Health and Wellbeing Strategy for Bristol Nick Hooper and Pat Diskett.
ProMISE Proactive Management and Integrated Services for the Elderly ProMISE The Bromley Programme Sam Merridale, Programme Lead June 2012.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
Sustainable Health and Green Care Donal O’Donoghue National Clinical Director for Kidney Care Green Nephrology Summit London Wednesday 26 th September.
Renal Services Dr Donal O’Donoghue National Clinical Director for Kidney Care UKRR Annual Audit Meeting QEH Birmingham 30 September 2010 Working for Better.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
NICE - in evidence based commissioning Gateshead Council Gillian Mathews, Implementation Consultant - North 9 September 2011.
- Progress in the last 40 years has been amazing but all health services, everywhere, still face 5 major problems one of which is unwarranted variation.
The National CKD Audit and Quality Improvement Programme for CKD in Primary Care The project will be advised by key stakeholders, including: From BMJ Informatica,
Consistent Implementation of the NSF for Renal Services Beverley Matthews Director – NHS Kidney Care.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
NHS Benchmarking Data Susan Hamilton Consultant in Public Health South Gloucestershire Council.
Diabetes Aspects of the Local Enhanced Service Dr Mark Barrett Dr Jeremy Sandford Dr Aythen Elkindi.
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
Prevalence Modelling – an APHO perspective Hannah Walford Eastern Region PHO With contributions from Julian Flowers, ERPHO Michael Soljak, Informing Healthier.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
NHSScotland Quality Strategy and Health Works Anne Hendry National Clinical Lead for Quality.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
UK Renal Registry Update 2010 and future plans. Chris Maggs Deputy Director.
Governance & Standards What is happening internationally Triona Fortune, March 2016.
Hyperphosphataemia in chronic kidney disease Support for education and learning for children and young people’s renal services: slide set March 2013 NICE.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Service user experience in adult mental health NICE quality standard January 2012.
Alcohol dependence and harmful alcohol use NICE quality standard August 2011.
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
Lead for the quantitative evaluation
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
UK Renal Registry 9th Annual Report 2006
CHAPTER 5 Paediatric Renal Replacement Therapy
Section 5: Configuration of healthcare to manage CKD
UK Renal Registry 14th Annual Report
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
UK Renal Registry 12th Annual Report
Presentation transcript:

Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information Day Tuesday 9th October 2012

“Quality is the only organising principle of the NHS” Sustainable Patient Centred Equitable Efficient Effective Timely Safe

CCG

4 Investigation QS1: Identification QS2: Specialist referral Progression and complications QS4: Cardiovascular risk QS5: Blood pressure control QS6: Progression QS7: Acute illness QS8: Anaemia treatment Preparing for renal replacement therapy QS9: Preparing for renal replacement therapy QS10: Psychosocial support Transplantation QS11: Transplantation – pre-emptive QS12: Transplantation – on dialysis Dialysis QS13: Dialysis access QS14: Best possible dialysis QS15: Patient transport End of life care NICE CKD Quality Standard 2011

Quality Standards the evidence base NICE Quality Standards Based on evidence of best practice and an assessment of current care Summarised evidence- based material: accredited guidance Primary research evidence is synthesised into other products – guidance, audit and service models NICE Quality Standards Guidance and related products Research and audit evidence

Quality Standards A Quality Standard is a set of specific, concise statements, based on guidance, that act as markers of high-quality, clinical and cost-effective patient care across a pathway or clinical area. There is a maximum of 15 in each set. They are accompanied by quality measures. UnsafeSubstandardAdequateGoodExcellent NICE quality standards Standard of services Proportion of services Registration requirements

Value in Health Care (Porter M: NEJM 363:2477, 2010, Lee: NEJM:363:2481, 2010) “Measurement of value is challenging…the critical first step is measurement. Provider organisations need to capture data on outcomes that matter to patients and carers.”

Waste Value Waste

NHS Atlas of Variation in Healthcare for People with Kidney Disease Renal Association Conference 2012 The Sage, Gateshead Thursday 14 th June 2012 To download the NHS Atlas of Variation in Healthcare for People with Kidney Disease, visit the Right Care website:

The Dartmouth Atlas of Healthcare, 1996

To download the NHS Atlas of Variation in Healthcare for People with Kidney Disease, visit the Right Care website:

To download the NHS Atlas of Variation in Healthcare for People with Kidney Disease, visit the Right Care website:

Health Survey England 2011

2010/11 CKD prevalence OE ratio Observed based on QOF 2010/11 prevalence Expected derived from HSE age and Gender prevalence estimates, applied to 2009 Mid year population estimates (ONS)

Prevalence of CKD:

Vascular Disease – One Event Leads to Another (REACH Registry) Original Event = Stroke MI Risk 2-3 x greater risk Stroke Risk 9 x greater risk Original Condition = PAD MI Risk 4 x greater risk Stroke Risk 2-3 x greater risk Original Event = MI MI Risk 5-7 x greater risk Stroke Risk 3-4 x greater risk Diabetes (type 2) Because of the increased risk associated with diabetes, it should be considered a cardiovascular risk equivalent to a non-diabetic patient with previous MI CKD MI Risk 2 x greater risk Stroke risk Up 50%

Trends in Late Referral by Year Late referral defined as ≤3 months before RRT start

Prevalent patients by treatment Demand for renal replacement therapy continues to increase RRT incident rates but incident rates appear to be reaching a plateau or falling

Percent distribution at initiation by eGFR The mean eGFR at initiation of RRT in 2009 in the UK was 8.6 The mean eGFR at initiation of RRT in 2008 in the US was 11.1 The mean eGFR at initiation of RRT is rising

Kidney transplants in the UK

Patient Involvement: a Paradigm Shift Old method New Method

Renal Patient View “ Grasping what the figures meant enabled us to formulate questions for consultations, to understand explanations and in some cases, since we were the first to see the figures in context, to alert consultants to changes as soon as they appeared. There is a sense that the relationship between the patient and the doctor becomes more collaborative as soon as the patient understands the figures before the consultation takes place… Because of the service, we feel we benefit more from consultations.”

Shared Decision Making The care team communicates to the patient personalised information about the options, outcomes, probabilities and scientific uncertainties of the various treatments. “is a fundamental part of care planning and promotes the best choice in what otherwise can be a complex and overwhelming situation.” The patient communicates his or her values and relative importance he or she places on the potential benefits and harms.

Patient Decision Aids